✦ LIBER ✦

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

✍ Scribed by Zelinkova, Zuzana; van der Ent, Cokkie; Bruin, Karlien F.; van Baalen, Onno; Vermeulen, Hestia G.; Smalbraak, Herman J.T.; Ouwendijk, Rob J.; Hoek, Aad C.; van der Werf, Sjoerd D.; Kuipers, Ernst J.; van der Woude, C. Janneke

Book ID: 122926574
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 627 KB
Volume: 11
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2012.10.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa2034 Early Discontinuation of Inflixim

Sa2034 Early Discontinuation of Infliximab During Pregnancy Reduces Neonatal Exposure to Infliximab and is Safe for the Inflammatory Bowel Disease Patients

✍ Zelinkova, Zuzana; van der Ent, Cokkie; Bruin, Karlien F.; van Baalen, Onno; Ver 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Mo1703 Incidence of Selected Adverse Eve

Mo1703 Incidence of Selected Adverse Events (AES) in Inflammatory Bowel Disease (IBD) Patients With and Without Exposure to Anti-Tumor Necrosis Factor Alpha (Anti-TNFa) Therapy

✍ McAuliffe, Megan E.; Leach, Tim; Fox, Irving; Lanes, Stephan; Faich, Gerald; Por 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Effect of the anti-tumor necrosis factor

Effect of the anti-tumor necrosis factor-α antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease

✍ Martin J. Meijer; Marij A.C. Mieremet-Ooms; Wim van Duijn; Annie M. van der Zon; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

## Background: Previous studies have shown an upregulation of matrix metalloproteinases (mmps) in intestinal tissue of patients with inflammatory bowel disease (ibd) and significant clinical improvement after administration of the anti-tnf-a antibody infliximab. the aims of our study were to determ

Tu1314 The Safety and Efficacy of Anti-T

Tu1314 The Safety and Efficacy of Anti-Tumor Necrosis Factor-Alpha Therapy for Inflammatory Bowel Disease in Patients Post-Liver Transplantation: A Case Series

✍ Sandhu, Amindeep S.; AlAmeel, Turki; Dale, Cheryl; Levstik, Mark; Chande, Nilesh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

OC.06.7: EFFECT OF MATRIX METALLOPROTEIN

OC.06.7: EFFECT OF MATRIX METALLOPROTEINASE (MMP)-3, -8, -10 AND -12 ON THE STRUCTURE AND FUNCTION OF ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS IN INFLAMMATORY BOWEL DISEASE

✍ P. Biancheri; A. Di Sabatino; S.A. Snoek; I. Joe-njoku; L. Rovedatti; N. Ahmad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

The effect of methotrexate and anti–tumo

The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON-YEARS of observation

✍ Frederick Wolfe; Kaleb Michaud 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 3 views

## Abstract ## Objective To ascertain the relationship between anti–tumor necrosis factor (anti‐TNF) therapy, methotrexate (MTX), and the risk of lymphoma in patients with rheumatoid arthritis (RA). This report updates our previous report during 29,314 person‐years of followup. ## Methods Partic